Anadolu Hayat Emeklilik AS (ANHYT) fair value: what the stock is really worth
As of Oct 30, 2026: fair value (intrinsic value) of Anadolu Hayat Emeklilik AS stock TRY 65.43, price TRY 87.95, that is 25.6% below the price, quality 48 out of 100. Rating: overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with oneYes, for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 1, 2026.
How to read this chart
60‑month range 6.65 TRY – 124.09 TRY · fair‑value band 54.52 TRY – 92.92 TRY · the 87.95 TRY price screens above the 65.43 TRY fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 1, 2026.
Follow Anadolu Hayat Emeklilik AS in your weekly email
Every Wednesday you see whether Anadolu Hayat Emeklilik AS is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Anadolu Hayat Emeklilik Anonim Sirketi provides private pension and life insurance products in Turkey.
Show moreShow less
The company offers private pension products, including individual, non-sponsored group, employer-sponsored, and income drawdown plans; auto-enrolment plans; and life insurance products, such as savings and endowment, annuities, and term life.
It also provides personal and group accident insurance products. In addition, the company provides conservative, balanced, dynamic, and aggressive pension funds. The company was formerly known as Anadolu Hayat Sigorta A.S. and changed its name to Anadolu Hayat Emeklilik Anonim Sirketi in 2003.
Anadolu Hayat Emeklilik Anonim Sirketi was founded in 1990 and is headquartered in Istanbul, Turkey. Anadolu Hayat Emeklilik Anonim Sirketi is a subsidiary of Türkiye Is Bankasi A.S.
Stock analysis
Anadolu Hayat Emeklilik AS (ANHYT) currently trades at 87.95 TRY, while our model-based Fair Value estimate is 65.43 TRY, 25.6% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Economic Profit group reads highest at a median of 65.43 TRY per share, and 1 of the 6 models we run sit above the 87.95 TRY price.
Bear case: the Asset-Based group reads lowest at 21.01 TRY, and 5 of the 6 models stay below the price. Data coverage for this calculation is high.
Scenario range: 54.52 TRY (bear) to 92.92 TRY (bull), the price of 87.95 TRY sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 48/100 (below-average quality), in the Financial Services sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Anadolu Hayat Emeklilik AS reported revenue of 37.4B TRL in FY2025 versus 4.9B TRL in FY2021, a compound +66.3%/yr. Reported net income was 6.0B TRL in FY2025, compounding +71.1%/yr from FY2021. FY2021 was a trough year, so the rate overstates the trend.
Key figures
Market cap 37.8B TRY (≈ $757M) Small · P/E ratio 5.3 · P/S ratio 0.88 · EPS (TTM) 16.51 TRY · Dividend yield 9.3% · Net margin 16.4% · Return on equity 59.1% · Return on assets (EBIT) 1.6%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 67 out of 100 (low confidence).
What moves the price
The share trades about 28% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Financial Services peers we cover trades at −40% fair-value upside, at −26%, ANHYT screens cheaper than that median.
Fair Value models
Bear54.52 TRYFair Value 65.43 TRYBull92.92 TRY
Price 87.95 TRY · Downside -25.6%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (7.02 TRY per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.100/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+60.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+67.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+67.0%
Start year 2020 (pandemic). Over 10 years: +45.3% a year
Revenue growth 24 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−32.5%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip.
+78.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year+69.1%
Dividend (yield on the price)9.3%
2025 sits 110% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−17.8%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Turkey: IMF forecast 19.3% a year to 2030, 28.5% from 2016 to 2025) that is about −31.1% a year for the price.
Compare Anadolu Hayat Emeklilik AS with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Insurance - Life · 77 stocks
Beats the industry median on 10/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score48 · Below median
Fair Value upside−25.6% · Below median
Profitability
Return on equity (12 months)59.1% · Top 25%
Return on assets1.4% · Above median
Net margin (12 months)16.4% · Above median
Operating margin (12 months)21.3% · Below median
Growth and dividend
Revenue growth (quarter YoY)29.2% · Top 25%
Dividend yield (12 months)9.3% · Top 25%
Valuation Multiplesvs Insurance - Life median · lower = cheaper
P/E (12 months)5.3× · Cheapest 25%
P/B2.77× · Priciest 25%
P/S (12 months)0.88× · Cheaper than median
Price / free cash flow4.1× · Cheaper than median
EV/EBITDA3.1× · Cheapest 25%
PEG0.89× · Cheaper than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 5
FUTURE (revenue growth)100· sector 45
PAST (return on equity)100· sector 52
HEALTH (low debt)0· sector 87
DIVIDEND (yield)100· sector 55
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Anadolu Hayat Emeklilik AS Fair Value". https://www.fairvalue-calculator.com/stock/ANHYT
Frequently asked questions
Is Anadolu Hayat Emeklilik AS (ANHYT) overvalued or undervalued?
As of Nov 1, 2026, our model estimates a fair value of 65.43 TRY versus a price of 87.95 TRY, about 26% lower (overvalued).
What is the fair value of ANHYT?
Our model-based fair value for Anadolu Hayat Emeklilik AS is 65.43 TRY (as of Nov 1, 2026), built from audited fundamentals. The current price: 87.95 TRY.
What is the quality score of ANHYT?
Anadolu Hayat Emeklilik AS has a Quality Score of 48/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Anadolu Hayat Emeklilik AS (ANHYT)?
Our model-based price target is the fair value of 65.43 TRY (as of Nov 1, 2026) from 6 valuation models. Cautious scenario 54.52 TRY, optimistic scenario 92.92 TRY. It is a calculation from audited fundamentals, not an analyst target.
What is the Anadolu Hayat Emeklilik AS stock forecast for 2026?
Our models put fair value at 65.43 TRY, about 26% lower versus a price of 87.95 TRY (overvalued). Cautious scenario 54.52 TRY, optimistic scenario 92.92 TRY. The calculation is refreshed regularly with new filings.
What is the revenue of Anadolu Hayat Emeklilik AS (ANHYT)?
Anadolu Hayat Emeklilik AS reported trailing-twelve-month revenue of about 43.2B TRY (latest available figure, as of Nov 1, 2026).
Does Anadolu Hayat Emeklilik AS pay a dividend?
Anadolu Hayat Emeklilik AS currently shows a dividend yield of 9.26% relative to its recent price (as of Nov 1, 2026).
What growth is priced into Anadolu Hayat Emeklilik AS (ANHYT)?
For today's price to be fair in a discounted-cash-flow model, Anadolu Hayat Emeklilik AS would have to grow free cash flow by -17.8 % per year for five years (discount rate 14.2 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +67.0 % per year. As of Nov 1, 2026.
What discount rate (WACC) does the fair value of ANHYT use?
Our models discount Anadolu Hayat Emeklilik AS at 14.2 %: a base by market capitalisation (small), damped by beta 0.19, country premium for Turkey. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Anadolu Hayat Emeklilik AS that is -17.8 % per year a year over ten years, using the same discount rate (14.2 %) and the same formula as our fair value.
How much growth has Anadolu Hayat Emeklilik AS (ANHYT) delivered so far?
Over the past 5 years revenue at Anadolu Hayat Emeklilik AS grew +67.0 % a year. The price currently implies -17.8 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Anadolu Hayat Emeklilik AS (ANHYT) growing?
The median revenue growth in the sector is +9.6 % a year. That is the yardstick for the growth priced into Anadolu Hayat Emeklilik AS (-17.8 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Anadolu Hayat Emeklilik AS (ANHYT)?
The free-cash-flow yield on the price is 24.45 %: that much free cash flow Anadolu Hayat Emeklilik AS produces per unit of market value. When it exceeds the discount rate of our models (14.2 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Anadolu Hayat Emeklilik AS (ANHYT)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Anadolu Hayat Emeklilik AS it is 65.43 TRY per share (as of Nov 1, 2026), against a price of 87.95 TRY. It is the blended result of 6 valuation models (cash flow, earnings, asset, dividend).
Is Anadolu Hayat Emeklilik AS stock overvalued or undervalued in 2026?
As of Nov 1, 2026, ANHYT trades above its calculated fair value: price 87.95 TRY, fair value 65.43 TRY, a gap of about −26% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ANHYT?
No. The price is what the market pays today (87.95 TRY); the fair value is what the company's own numbers justify (65.43 TRY). For Anadolu Hayat Emeklilik AS the two are 22.52 TRY per share apart. That gap is exactly why we show both numbers side by side.
How much is Anadolu Hayat Emeklilik AS worth?
The market values Anadolu Hayat Emeklilik AS at about 37.8B TRY (market capitalisation, as of Nov 1, 2026). Per share that is 87.95 TRY; our models calculate a fair value of 65.43 TRY per share.
What do the bullish and bearish scenarios say about ANHYT?
Our models span a range for Anadolu Hayat Emeklilik AS: cautious scenario 54.52 TRY, base 65.43 TRY, optimistic 92.92 TRY per share (as of Nov 1, 2026, price 87.95 TRY). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of ANHYT?
Anadolu Hayat Emeklilik AS trades at a price-to-earnings ratio of 5.3 (as of Nov 1, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 65.43 TRY is built from several models across several years. Other multiples: PEG 0.9, P/B 2.8, P/S 0.9, EV/EBITDA 3.1.
What is the PEG ratio of ANHYT?
The PEG ratio of Anadolu Hayat Emeklilik AS is 0.89 (P/E divided by earnings growth, as of Nov 1, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of Anadolu Hayat Emeklilik AS (ANHYT)?
Balance-sheet figures for Anadolu Hayat Emeklilik AS (as of Nov 1, 2026): return on equity 59.1%. They feed the Quality Score of 48/100, which measures business quality independently of the share price.
How far is ANHYT from its 52-week high?
Anadolu Hayat Emeklilik AS trades at 87.95 TRY, about 28% below its 52-week high of 122.50 TRY and at the low of 87.95 TRY (as of Oct 30, 2026). Distance from the high says nothing about value: that is what the fair value of 65.43 TRY is for.
Which stocks are comparable to Anadolu Hayat Emeklilik AS?
From the same area (Financial Services) we also value Ping An Insurance (Group) Company, China Life Insurance Company, AIA Group, Manulife Financial Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Anadolu Hayat Emeklilik AS stock attractive at the current price?
The data as of Nov 1, 2026: price 87.95 TRY, calculated fair value 65.43 TRY (−26%), Quality Score 48/100, from 6 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ANHYT calculated?
We run Anadolu Hayat Emeklilik AS through 6 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 65.43 TRY, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.9 % above its aggregate fair value. Anadolu Hayat Emeklilik AS itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Anadolu Hayat Emeklilik AS (ANHYT)?
The closing price on Oct 30, 2026 was 87.95 TRY. Our model-based fair value is 65.43 TRY, about 26% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Anadolu Hayat Emeklilik AS right now?
Weak quality (48/100) and above fair value at the same time, the margin of safety is missing on both counts. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Key figures of Anadolu Hayat Emeklilik AS
How large is the market capitalisation of Anadolu Hayat Emeklilik AS (ANHYT)?
The market capitalisation of Anadolu Hayat Emeklilik AS is 37.8B TRY (≈ $757M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Anadolu Hayat Emeklilik AS (ANHYT)?
The price-to-sales ratio of Anadolu Hayat Emeklilik AS is 0.88 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Anadolu Hayat Emeklilik AS (ANHYT)?
Earnings per share at Anadolu Hayat Emeklilik AS are 16.51 TRY (price ÷ EPS = P/E 5.3). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Anadolu Hayat Emeklilik AS (ANHYT)?
The dividend yield of Anadolu Hayat Emeklilik AS is 9.3% (payout 49.3%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Anadolu Hayat Emeklilik AS (ANHYT)?
The net margin of Anadolu Hayat Emeklilik AS is 16.4% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Anadolu Hayat Emeklilik AS (ANHYT)?
The return on equity (ROE) of Anadolu Hayat Emeklilik AS is 59.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Anadolu Hayat Emeklilik AS (ANHYT)?
On an EBIT basis the return on assets of Anadolu Hayat Emeklilik AS is 1.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Anadolu Hayat Emeklilik AS (ANHYT)?
The operating margin of Anadolu Hayat Emeklilik AS is 21.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Anadolu Hayat Emeklilik AS (ANHYT)?
Revenue at Anadolu Hayat Emeklilik AS is growing +29.2% versus a year earlier (3y avg +67.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Anadolu Hayat Emeklilik AS (ANHYT)?
Earnings per share at Anadolu Hayat Emeklilik AS are growing +42.4% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed
Watch Anadolu Hayat Emeklilik AS in the live analysis
One click puts Anadolu Hayat Emeklilik AS on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 1, 2026